1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Sonic Healthcare Limited
  6. Financials
    SHL   AU000000SHL7

SONIC HEALTHCARE LIMITED

(SHL)
  Report
Delayed Australian Stock Exchange  -  02:10 2022-08-18 am EDT
34.10 AUD   -0.87%
08/08Proteomics International Signs Deal for Potential Distribution of Kidney Disease Test PromarkerD in US; Shares Rally 11%
MT
06/20SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/15SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Capitalization1 12 84414 46018 35216 229--
Enterprise Value (EV)1 15 14317 84520 68717 44317 17916 869
P/E ratio 22,2x27,5x14,1x11,7x19,1x21,4x
Yield 3,10%2,79%2,37%2,85%3,12%3,13%
Capitalization / Revenue 2,09x2,12x2,10x1,76x1,99x1,98x
EV / Revenue 2,47x2,61x2,36x1,89x2,10x2,05x
EV / EBITDA 14,3x12,5x8,08x6,37x8,97x9,31x
Price to Book 2,37x2,55x2,87x2,21x2,14x2,07x
Nbr of stocks (in thousands) 473 945475 174477 907471 771--
Reference price (AUD) 27,130,438,434,434,434,4
Announcement Date 08/19/201908/19/202008/23/2021---
1 AUD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net sales1 6 1346 8328 7529 2138 1718 209
EBITDA1 1 0611 4252 5602 7391 9151 813
Operating profit (EBIT)1 7888191 9182 0701 2481 123
Operating Margin 12,8%12,0%21,9%22,5%15,3%13,7%
Pre-Tax Profit (EBT)1 7226991 8292 0131 1881 068
Net income1 5505281 3151 408853760
Net margin 8,96%7,72%15,0%15,3%10,4%9,26%
EPS2 1,221,112,732,941,801,61
Dividend per Share2 0,840,850,910,981,071,08
Announcement Date 08/19/201908/19/202008/23/2021---
1 AUD in Million
2 AUD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: June 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales1 4 4324 3194 7574 5014 0203 930
EBITDA1 1 3071 2531 5401 184976945
Operating profit (EBIT)1 9949241 208838599554
Operating Margin 22,4%21,4%25,4%18,6%14,9%14,1%
Pre-Tax Profit (EBT)1 9448851 168796--
Net income1 678637828572419402
Net margin 15,3%14,8%17,4%12,7%10,4%10,2%
EPS2 1,411,321,711,210,870,82
Dividend per Share ------
Announcement Date 02/17/202108/23/202102/20/2022---
1 AUD in Million
2 AUD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net Debt1 2 2993 3862 3351 214950640
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,17x2,38x0,91x0,44x0,50x0,35x
Free Cash Flow1 5661 1251 7691 6521 145995
ROE (Net Profit / Equities) 11,5%9,46%22,0%20,9%11,6%9,87%
Shareholders' equity1 4 7955 5785 9796 7527 3647 703
ROA (Net Profit / Asset) 6,05%4,78%11,0%11,8%7,02%6,13%
Assets1 9 08011 04411 94411 97112 15712 403
Book Value Per Share2 11,411,913,415,616,116,6
Cash Flow per Share2 1,882,854,244,033,313,01
Capex1 282235274327346362
Capex / Sales 4,59%3,44%3,13%3,55%4,24%4,41%
Announcement Date 08/19/201908/19/202008/23/2021---
1 AUD in Million
2 AUD
Previous periodNext period
Estimates
Key data
Capitalization (AUD) 16 228 934 405
Capitalization (USD) 11 226 434 979
Net sales (AUD) 8 751 514 000
Net sales (USD) 6 053 897 344
Number of employees 38 000
Sales / Employee (AUD) 230 303
Sales / Employee (USD) 159 313
Free-Float 95,4%
Free-Float capitalization (AUD) 15 487 580 763
Free-Float capitalization (USD) 10 713 600 417
Avg. Exchange 20 sessions (AUD) 37 414 297
Avg. Exchange 20 sessions (USD) 25 881 500
Average Daily Capital Traded 0,23%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA